ARSA (Search Result) Help

Search Result

Facet

Division

now loading

    Organism_facet

    now loading

      List of Entries

      1 - entries / Number of founds: 124  
        PrimaryAccessionNumber Definition SequenceLength MolecularType Organism
      N22245 yw34g08.s1 Morton Fetal Cochlea Homo sapiens cDNA clone IMAGE:254174 3' similar to gb:M64241 QM PROTEIN (HUMAN), mRNA sequence. 280 mRNA Homo sapiens
      LF829401 JP 2016528161-A/22234: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS. 18 RNA synthetic construct
      LV568067 JP 2017029159-A/22245: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS. 40 DNA synthetic construct
      DM758939 JP 2014079248-A/22245: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      FU796726 JP 2009528046-A/22243: Method for identifying useful proteins of brewery yeast. 25 DNA Saccharomyces pastorianus
      DD548848 JP 2004508801-A/22245: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      DJ526045 JP 2010517930-A/22245: Method of constructing and screening libraries of peptide structures. 30 PRT synthetic construct
      DJ151625 JP 2007228956-A/22243: Method for identification of useful proteins derived from brewery yeast. 25 DNA Saccharomyces pastorianus
      PA337893 JP 2021522188-A/22245: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation. 20 DNA synthetic construct
      DL612847 JP 2011092200-A/22245: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      MC774355 JP 2018525446-A/22245: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF. 32 PRT synthetic construct
      PA526729 JP 2022502046-A/9511: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY. 21 DNA synthetic construct
      OG751764 JP 2021120380-A/22245: CANCER NEOEPITOPES. 9 PRT Homo sapiens
      MD754487 JP 2019507579-A/22245: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY. 20 DNA synthetic construct
      MC164089 JP 2019500349-A/22245: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES. 18 RNA synthetic construct
      LX119861 JP 2017506877-A/22243: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes. 16 DNA synthetic construct
      HZ527026 JP 2016501039-A/22245: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS. 40 DNA synthetic construct
      LF681466 JP 2016521556-A/22245: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION. 15 DNA Homo sapiens
      HW857469 JP 2015051004-A/22197: Novel siRNA's and Use Thereof. 21 RNA synthetic construct
      MD268378 JP 2020517247-A/22245: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof. 20 DNA synthetic construct
      DM796703 JP 2014068652-A/22245: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      HV878786 JP 2010507387-A/22197: Novel siRNAs and Methods of Use Thereof. 21 RNA synthetic construct
      DL031259 JP 2005512499-A/22245: Diagnosis of existing illnesses or that praedisposition for determined illnesses. 822 DNA synthetic construct
      PA392968 JP 2021533803-A/22051: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE. 26 DNA Homo sapiens
      MC550745 JP 2019525738-A/22245: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES. 118 PRT synthetic construct
      MB811503 JP 2019502674-A/22245: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF. 36 PRT synthetic construct
      DL903989 JP 2014205669-A/22245: Method of constructing and screening libraries of peptide structures. 30 PRT synthetic construct
      HW187273 JP 2013102767-A/22197: Novel siRNA's and Use Thereof. 21 RNA synthetic construct
      DJ952606 JP 2010500568-A/39287: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE. 1258 PRT Homo sapiens
      DD802515 JP 2008525033-A/22245: Group B Streptococcus. 831 PRT Streptococcus agalactiae
      Now loading
      PAGE TOP